Close Menu

NEW YORK ─ Avalon GloboCare said on Wednesday that it has entered into a commercialization partnership to market and distribute Cellex's COVID-19 antibody-based rapid test kit.

This agreement allows Avalon, a developer of cell-based technologies and therapeutics, to initiate distribution and marketing of the test to its designated network of channel partners and distributor affiliates in the US and internationally.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.